Pharma marketing leaders are being forced to rethink and possibly accelerate their investments in non-personal promotion, as COVID-19 has created a massive disruption in the industry’s traditional selling channels (live reps and conferences). These best practices will help marketers take steps to enhance their communications with HCPs in a period of great change and uncertainty.
- Gartner client? Log in for personalized search results.
Insight Report July 30, 2020
Best Practices for Accelerating the Use of Non-Personal Promotion in Pharma Marketing
Gartner is a trusted advisor and an objective resource for more than 15,000 enterprises in 100+ countries.
Learn more about how we can help you achieve your mission-critical priorities.